Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[The quantitative testing of V617F mutation in gen JAK2 using pyrosequencing technique].

Klinicheskaia laboratornaia diagnostika - 1 Nov 2014

Dunaeva E A, Mironov K O, Dribnokhodova T E, Subbotina E E, Bashmakova, Ol'hovskiĭ I A, Shipulin G A

Abstract excerpt

The somatic mutation V617F in gen JAK2 is a frequent cause of chronic myeloprolific diseases not conditioned by BCR/ABL mutation. The quantitative testing of relative percentage of mutant allele can be used in establishing severity of disease and its prognosis and in prescription of remedy inhibiting activity of JAK2. To quantitatively test mutation the pyrosequencing technique was applied. The developed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BCR gene
Share to JAK2 gene
Share to High-Throughput Nucleotide Sequencing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Janus Kinase 2

Share to Mutation

Share to Myeloproliferative Disorders

Source

Identifiers

PMID: 25850251

Genes

JAK2
BCR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[The quantitative testing of V617F mutation in gen JAK2 using pyrosequencing technique].PMID 25850251Read ↗

[JAK2 mutation can be used in diagnosis of myeloproliferative diseases].Semantic proximity Read ↗

[Research progress on gene mutation of jak2].Semantic proximity Read ↗

[Pathogenetic role of JAK2 gene mutation in chronic myeloproliferative disorders].Semantic proximity Read ↗

JAK2 V617F in myeloid disorders: molecular diagnostic techniques and their clinical utility: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology.Semantic proximity Read ↗

Clinical applications of molecular haematology: JAK2 in myeloproliferative disorders.Semantic proximity Read ↗

[Detection of JAK2V617F mutation rate by real-time fluorescent quantitative PCR using allele specific primer and TaqMan-MGB probe for dual inhibiting amplification of wild type alleles].Semantic proximity Read ↗

[Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].Semantic proximity Read ↗

The V617F JAK2 mutation and the myeloproliferative disorders.Semantic proximity Read ↗

[Somatic mutation of the V617F JAK2 gene in patients of the cardiovascular diseases].Semantic proximity Read ↗

Validation of two clinically useful assays for evaluation of JAK2 V617F mutation in chronic myeloproliferative disordersSemantic proximity Read ↗

[JAK2V617F mutation in the patients with myeloproliferative disorder and its relation with clinical characteristics].Semantic proximity Read ↗

Detection Mutations of JAK2 exon 12 in Patients with JAK2 (V617F)-negative Myeloproliferative Disorders.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.